Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lindsay McCaw
Persistent Janus Kinase-Signaling in Chronic Lymphocytic Leukemia Patients on Ibrutinib: Results of a Phase I Trial
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Related publications
Activity of the Janus Kinase Inhibitor Ruxolitinib in Chronic Lymphocytic Leukemia: Results of a Phase II Trial
Haematologica
Hematology
Beyond Ibrutinib Resistance in Chronic Lymphocytic Leukemia
Cancer therapy & Oncology International Journal
Phase 2 Study of Acalabrutinib in Ibrutinib-Intolerant Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Anticoagulant Therapy in Patients With Chronic Lymphocytic Leukemia Receiving Ibrutinib
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
A Phase I/Ii Trial of TLR-7 Agonist Immunotherapy in Chronic Lymphocytic Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Amebic Encephalitis in a Patient With Chronic Lymphocytic Leukemia on Ibrutinib Therapy
Case Reports in Hematology
Bruton's Tyrosine Kinase Inhibitor Restrains WNT Signaling in Chronic Lymphocytic Leukemia
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Arresting the Inflammatory Drive of Chronic Lymphocytic Leukemia With Ibrutinib
Clinical Cancer Research
Cancer Research
Oncology
Ibrutinib Therapy Releases Leukemic Surface IgM From Antigen Drive in Chronic Lymphocytic Leukemia Patients.
Clinical Cancer Research
Cancer Research
Oncology